earnings
confidence high
sentiment positive
materiality 0.70
Health Catalyst Q3 revenue $76.4M, Adj. EBITDA $7.3M; acquires Intraprise for $43M
Health Catalyst, Inc.
2024-Q3 EPS reported
-$0.82
revenue$226,978,000
- Q3 2024 total revenue $76.4M, net loss $14.7M, Adjusted EBITDA $7.3M (above guidance midpoint of $6-8M).
- FY 2024 Adjusted EBITDA guidance raised to $25-27M (from $24-26M); revenue guidance unchanged at $305-311M.
- Acquired Intraprise Health for $43M (cash and ~2.2M shares at $8.18); expected close by end of 2024, immaterial near-term financial impact.
- Appointed Dr. Jill Hoggard Green to board effective Dec 1, 2024; she is former CEO of The Queens Health System, a client.